InvestLog
LYRA logo

LYRA

Lyra Therapeutics, Inc.NASDAQHealthcare
$0.44-11.98%ClosedMarket Cap: $781,126

As of 2026-04-04

Insider Statistics (Q2 2026)

Purchases

0

Sales

2

Buy/Sell Ratio

0.00

Total Bought

$0.00

Total Sold

$0.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Fri Apr 03Cavalier Jasonofficer: Principal Financial OfficerSell667$0.00517,880
Fri Apr 03Palasis Mariadirector, officer: Principal Executive OfficerSell2,000$0.001,094,733
Thu Jan 08Cavalier Jasonofficer: Chief Financial OfficerSell769$3.36518,547
Thu Jan 08Palasis Mariadirector, officer: President & CEOSell1,702$3.361,096,733
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell28,597$3.90124,859
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell537$4.3118,122
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell883$4.0617,239
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell3,213$3.9014,026
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell7,862$4.06153,456
Thu Nov 13PERCEPTIVE ADVISORS LLC10 percent ownerSell4,783$4.31161,318
Mon Nov 10PERCEPTIVE ADVISORS LLC10 percent ownerSell28,902$5.18200,480
Mon Nov 10PERCEPTIVE ADVISORS LLC10 percent ownerSell17,746$4.75182,734